Plasma Indoleamine 2,3-Dioxygenase Concentration is Increased in Hemodialysis Patients and May Contribute to the Pathogenesis of Coronary Heart Disease
Authors:
- Theodoros EleftheriadisTheodoros Eleftheriadis
- Georgia AntoniadiGAGeorgia Antoniadi
- Vassilios LiakopoulosVassilios Liakopoulos
- Ioannis StefanidisISIoannis Stefanidis
- Grammati GalaktidouGGGrammati Galaktidou
- 21 October 2011
- journal article
- Published by Taylor & Francis in Renal Failure
- Vol. 34 (1) , 68-72
Abstract
Introduction: Coronary heart disease (CHD) is the leading cause of death in hemodialysis (HD) patients. Inflammation contributes to the pathogenesis of atherosclerosis in this population. Indoleamine 2,3-dioxygenase (IDO), an enzyme with immunomodulatory properties, was evaluated in HD patients with or without CHD. Methods: Of the total of 66 HD patients, 22 of them with CHD were confirmed by coronary angiography and 24 healthy volunteers were enrolled in the study. Plasma IDO was assessed by means of enzyme-linked immunosorbent assay. Serum interleukin-6 (IL-6) and C-reactive protein (CRP) were also measured. Results: Compared with healthy volunteers, plasma IDO concentration was markedly increased in HD patients (median 8.04 ng/mL vs. 48.9 ng/mL). Serum IL-6 and CRP were also significantly increased in HD patients. Compared with HD patients without CHD, plasma IDO concentration was significantly increased in HD patients with CHD (median 38.6 ng/mL vs. 74.5 ng/mL). Neither IL-6 nor CRP differed between the last two groups. IDO was negatively correlated with IL-6 and CRP. Conclusion: IDO concentration is increased in HD patients and is increased further in HD patients with CHD. It remains to be elucidated if increased IDO plays a direct role in the pathogenesis of atherosclerosis or if it affects atherosclerosis indirectly by curtailing chronic inflammation or bothKeywords
This publication has 28 references indexed in Scilit:
- Enhanced degradation of tryptophan in patients on hemodialysisClinical Nephrology, 2010
- Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patientsHemodialysis International, 2010
- Kynurenine is an endothelium-derived relaxing factor produced during inflammationNature Medicine, 2010
- Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow ConditionsJournal of Biological Chemistry, 2009
- Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesBlood, 2009
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenaseProceedings of the National Academy of Sciences, 2008
- Chronic Inflammation and CD16+ Natural Killer Cell Zeta-Chain Downregulation in Hemodialysis PatientsBlood Purification, 2008
- Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns StudyClinical and Experimental Immunology, 2007
- The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokersClinical and Experimental Immunology, 2006
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999